000 01645 a2200445 4500
005 20250513085910.0
264 0 _c19960517
008 199605s 0 0 eng d
022 _a0090-1229
024 7 _a10.1006/clin.1996.0040
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKitsuki, H
245 0 0 _aInduction of inflammatory cytokines in effusion cavity by OK-432 injection therapy for patients with malignant effusion: role of interferon-gamma in enhancement of surface expression of ICAM-1 on tumor cells in vivo.
_h[electronic resource]
260 _bClinical immunology and immunopathology
_cMar 1996
300 _a283-90 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAged
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aAscitic Fluid
_xtherapy
650 0 4 _aCell Membrane
_xmetabolism
650 0 4 _aCytokines
_xbiosynthesis
650 0 4 _aHumans
650 0 4 _aInjections
650 0 4 _aIntercellular Adhesion Molecule-1
_xbiosynthesis
650 0 4 _aInterferon-gamma
_xbiosynthesis
650 0 4 _aInterleukin-1
_xbiosynthesis
650 0 4 _aMale
650 0 4 _aPicibanil
_xtherapeutic use
650 0 4 _aPleural Effusion, Malignant
_xtherapy
650 0 4 _aTumor Cells, Cultured
650 0 4 _aTumor Necrosis Factor-alpha
_xbiosynthesis
700 1 _aKatano, M
700 1 _aIkubo, A
700 1 _aMorisaki, T
700 1 _aAnann, K
700 1 _aTanaka, M
700 1 _aTorisu, M
773 0 _tClinical immunology and immunopathology
_gvol. 78
_gno. 3
_gp. 283-90
856 4 0 _uhttps://doi.org/10.1006/clin.1996.0040
_zAvailable from publisher's website
999 _c8604752
_d8604752